There are currently 105 clinical trials in Lubbock, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including Texas Tech University Health Sciences Center, Covenant Children's Hospital, Joe Arrington Cancer Research and Treatment Center and UMC Cancer Center / UMC Health System. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Naltrexone for Prolonged Grief Disorder
NCT06140420
Recruiting
This is a study to see how effective oral naltrexone is as treatment for prolonged grief disorder (PGD). Participants will take their assigned medication for 8 weeks, with monthly visits to assess symptom severity, social connectedness, and adverse reactions.
Gender:
All
Ages:
Between 18 years and 120 years
Trial Updated:
11/14/2023
Locations: Texas Tech Health Science Center, Lubbock, Texas
Conditions: Naltrexone HCl 50 MG Oral Tablet, Placebo
Register for Updates
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
NCT05811364
Recruiting
The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/07/2023
Locations: Texas Tech University Health Science Center, Lubbock, Texas
Conditions: Aortoiliac Occlusive Disease, Peripheral Arterial Disease
Register for Updates
Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery
NCT02793492
Recruiting
This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/25/2023
Locations: Texas Tech University Health Sciences Center, Lubbock, Texas
Conditions: Iliac Artery Stenosis
Register for Updates
The Effect of 4 Weeks of L-Citrulline Supplementation on Macro- and Microvascular Function in Type 2 Diabetes
NCT06016478
Recruiting
The purpose of this study is to examine the effect of 4 weeks of Citrulline supplementation on macro- and microvascular function during acute hyperglycemia in middle-aged and older adults with type 2 diabetes.
Gender:
All
Ages:
Between 40 years and 75 years
Trial Updated:
10/10/2023
Locations: TTU Kinesiology and Sport Management Building, Lubbock, Texas
Conditions: Type 2 Diabetes
Register for Updates
Molecular Genetics Studies of Cancer Patients and Their Relatives
NCT04185935
Recruiting
This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.
Gender:
All
Ages:
All
Trial Updated:
09/21/2023
Locations: Covenant Medical Center, Lubbock, Texas
Conditions: Malignant Neoplasm
Register for Updates
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
NCT05408559
Recruiting
Our local IRB approved clinical studies seeking proof of principle for the hypothesis that SFN can be safely administered to humans at doses sufficient to protect age-associated cardiac dysfunctions. Beneficial effects of SFN-therapy will be assessed by Pre- and post-intervention echocardiography, and exercise endurance at 0 and 24 weeks. Peripheral blood cells from treated and control subjects will be compared for mitochondrial respiratory function, oxidative damage, pro-inflammatory cytokines,... Read More
Gender:
All
Ages:
Between 60 years and 80 years
Trial Updated:
09/15/2023
Locations: Texas Tech University Health Sciences Center (TTUHSC), Lubbock, Texas
Conditions: Diastolic Dysfunction, Systolic Dysfunction, Diastolic Heart Failure
Register for Updates
Study of Kidney Tumors in Younger Patients
NCT00898365
Recruiting
This research trial studies kidney tumors in younger patients. Collecting and storing samples of tumor tissue, blood, and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.
Gender:
All
Ages:
29 years and below
Trial Updated:
09/06/2023
Locations: Covenant Children's Hospital, Lubbock, Texas +1 locations
Conditions: Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, Angiolipoma, Cellular Congenital Mesoblastic Nephroma, Classic Congenital Mesoblastic Nephroma, Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma, Cystic Partially Differentiated Kidney Nephroblastoma, Diffuse Hyperplastic Perilobar Nephroblastomatosis, Extrarenal Rhabdoid Tumor, Kidney Medullary Carcinoma, Kidney Neoplasm, Kidney Oncocytoma, Kidney Wilms Tumor, Metanephric Adenofibroma, Metanephric Adenoma, Metanephric Stromal Tumor, Metanephric Tumor, Mixed Congenital Mesoblastic Nephroma, Ossifying Renal Tumor of Infancy, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Rhabdoid Tumor of the Kidney, Wilms Tumor
Register for Updates
Effects of L-citrulline Supplementation on Vascular Function in Metabolic Syndrome
NCT06025357
Recruiting
The objective of this project is to provide evidence that L-Citrulline (CIT) supplementation can improve vascular function in the fasted and acute hyperglycemia conditions in middle-aged and older women with metabolic syndrome.
Gender:
Female
Ages:
Between 45 years and 79 years
Trial Updated:
08/29/2023
Locations: TTU Kinesiology and Sport Management Building, Lubbock, Texas
Conditions: Metabolic Syndrome, Menopause
Register for Updates
2 Weeks of Citrulline Supplementation on Arterial Function in Postmenopausal Women With Elevated Blood Pressure or Hypertension
NCT06025383
Recruiting
The objective of this project is to elucidate the effect of L-Citrulline (L-CIT) supplementation on vascular function at rest and during rhythmic handgrip exercise and functional sympatholysis via lower-body negative pressure in postmenopausal women with elevated blood pressure and hypertension.
Gender:
Female
Ages:
Between 50 years and 70 years
Trial Updated:
08/29/2023
Locations: Texas Tech University, Lubbock, Texas
Conditions: Menopause, Hypertension
Register for Updates
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT03851445
Recruiting
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
08/28/2023
Locations: Covenant Medical Center-Lakeside, Lubbock, Texas
Conditions: Previously Treated Non-Small Cell Lung Cancer
Register for Updates
Curcumin and Retinal Study
NCT05774704
Recruiting
To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.
Gender:
All
Ages:
Between 40 years and 89 years
Trial Updated:
08/21/2023
Locations: Texas Tech University Health Sciences Center, Lubbock, Texas
Conditions: Bioavailability, Gut Microbiome, Safety
Register for Updates
Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends
NCT04865679
Recruiting
This pilot study evaluates the tolerability and feasibility of the Axoguard Large-Diameter Nerve Cap (sizes 5-7 mm) for protecting and preserving terminated nerve endings after limb trauma or amputation when immediate attention to the nerve injuries is not possible.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
08/17/2023
Locations: Texas Tech University, Health Science Center, Lubbock, Texas
Conditions: Symptomatic Neuroma, Amputation, Chronic Nerve Pain
Register for Updates